CDRD Ventures Inc., and Pfizer Announcement Showcases Today’s Investment for Health Innovation

  CDRD Ventures Inc., and Pfizer Announcement Showcases Today’s Investment for
  Health Innovation

Business Wire

VANCOUVER, British Columbia -- February 21, 2013

BIOTECanada, the national industry association representing 250 biotechnology
companies today congratulates CDRD Ventures Inc., (CVI), the commercialization
vehicle of The Centre for Drug Research and Development (CDRD) and Pfizer on
their announcement of a new strategic collaboration aimed at advancing
Canada’s most promising health technologies towards commercialization.

“Canada is home to hundreds of research enterprises in almost every region
across the countrydeveloping truly game-changing therapies and treatments to
significantly improve health care for thousands of Canadians, and thousands
more globally, who suffer from debilitating or life threatening illnesses,”
commented Andrew Casey, President and CEO BIOTECanada. “The success of these
undertakings is highly dependent on capital and partnerships with larger
biotechnology companies. The CVI-Pfizer partnership announced today serves as
an excellent example of the new biotech-health business model where
commercialized companies interconnect with smaller companies and research
enterprises fostering an eco-system to move research from an idea in the lab
to a bona fide treatment in the health care system.”

Biotechnology plays an important role as a preventative tool and modern
treatments for cancer, blood disorders and respiratory illness in the health
care system. Screening patients for susceptibility to disease and providing
vaccinations has impacted millions of Canadians. With biotechnology, we can
glean understanding of our genetic code, improving our collective health.
These advances offer doctors the tools to prevent and cure diseases with a
personalized approach.

The Canadian life sciences sector continues to show determination and
resiliency. The industry is seeking in excess of $1 billion of capital to help
Canadian companies grow and develop. Through diverse products and process
developments, Canadian biotechnology companies are boosting commercial
productivity in agriculture, healthcare, energy, and advanced manufacturing.

BIOTECanada is the national industry association with nearly 250 members
located nation wide, reflecting the diverse nature of Canada’s health,
industrial and agricultural biotechnology sectors.

Contact:

BIOTECanada
Nadine Lunt, 613-230-5585 x257
 
Press spacebar to pause and continue. Press esc to stop.